LncRNA - 基因组修饰交叉声:编排癌症病理生物学
Saade Abdalkareem Jasim1, Harikumar Pallathadka2, Ahmed Hjazi3
1Medical Laboratory Techniques Department, College of Health and Medical Technology, University of Al-Maarif, Anbar, Iraq. saad.a.j.anbar@gmail.com.
Naunyn-Schmiedeberg's archives of pharmacology
|July 11, 2025
概括
长非编码RNAs (lncRNAs) 和基因素修饰是癌症中至关重要的表观遗传调节剂. 它们的交叉声会影响瘤的发展,为新的诊断生物标志物和精确的癌症疗法提供潜力.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- 长非编码RNAs (lncRNAs) 和基因素修饰是癌症中的关键表观遗传调节剂.
- 质子的修改 (甲基化,乙化,酸化,泛化) 影响染色体结构和基因表达.
- lncRNAs通过信号,脚手架,诱惑和指导来改变细胞通路而起作用.
研究的目的:
- 审查 lncRNAs 和癌症中的基因组修饰之间的复杂交叉.
- 为了突出这一交叉语音在瘤启动和进展中的作用.
- 探索诊断,预后和治疗的临床影响.
主要方法:
- 在癌症中对lncRNA-海斯修饰相互作用的文献综述.
- 对基因组修饰酶的 lncRNA 招募的分析.
- 在癌症病理生物学中检查特定的lncRNAs (HOTAIR,MALAT1,LINC00152,SNHG1).
主要成果:
- lncRNAs招募基因基因修饰酶来调节基因表达.
- 异常的lncRNA表达与瘤开始,进展和转移有关.
- lncRNA-海斯修饰交叉对生物标志物和疗法提供了机会.
结论:
- 在癌症中,lncRNA和基因组修饰是重要的表观遗传参与者.
- 失调的 lncRNA-希斯相互作用驱动瘤发生.
- 针对这些相互作用为精密瘤治疗提供了有前途的途径.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
02:32Histone Modification
3.6K
3.6K
01:37Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
02:25Spreading of Chromatin Modifications
8.5K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.5K
02:30Histone Variants at the Centromere
4.5K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.5K
01:19Interactions Between Signaling Pathways
6.5K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.5K